FDA approval timeline As retatrutide moves closer to FDA approval (projected for 2027 to 2028), the research peptide market will evolve
Bioengineered nanomedicines targeting the intestinal fc receptor achieve the improved glucoregulatory effect of semaglutide in a type 2 diabetic mice model
References Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschp MH
There is a growing market for unlicensed, compounded, or counterfeit peptides sold online, and the MHRA has issued warnings about the serious risks associated with purchasing injectable medicines from unregulated sources including contamination, incorrect or unknown dosing, and harmful impurities
In early trials, average weight loss reached 25% by week 4 and up to 24.2% by 48 weeks (12mg dose)